Pär Johansson from Copenhagen joins Rob Mac Sweeney to discuss the fascinating phase II COMBAT-COVID trial, investigating prostacyclin in intubated patients with COVID-19 and severe
endotheliopathy. The trial was published in the American Journal of Respiratory and Critical Care Medicine in November 2021.
